Vis enkel innførsel

dc.contributor.authorHenjum, Helge
dc.contributor.authorDahle, Tordis Johnsen
dc.contributor.authorMairani, Andrea
dc.contributor.authorPilskog, Sara Margareta Cecilia
dc.contributor.authorStokkevåg, Camilla Hanquist
dc.contributor.authorBoer, Camilla Grindeland
dc.contributor.authorRedalen, Kathrine Røe
dc.contributor.authorMinn, Heikki
dc.contributor.authorMalinen, Eirik
dc.contributor.authorYtre-Hauge, Kristian Smeland
dc.date.accessioned2024-01-17T10:16:45Z
dc.date.available2024-01-17T10:16:45Z
dc.date.created2023-05-26T10:29:46Z
dc.date.issued2023
dc.identifier.issn1526-9914
dc.identifier.urihttps://hdl.handle.net/11250/3112093
dc.description.abstractIntroduction Tumor hypoxia is associated with poor treatment outcome. Hypoxic regions are more radioresistant than well-oxygenated regions, as quantified by the oxygen enhancement ratio (OER). In optimization of proton therapy, including OER in addition to the relative biological effectiveness (RBE) could therefore be used to adapt to patient-specific radioresistance governed by intrinsic radiosensitivity and hypoxia. Methods A combined RBE and OER weighted dose (ROWD) calculation method was implemented in a FLUKA Monte Carlo (MC) based treatment planning tool. The method is based on the linear quadratic model, with α and β parameters as a function of the OER, and therefore a function of the linear energy transfer (LET) and partial oxygen pressure (pO2). Proton therapy plans for two head and neck cancer (HNC) patients were optimized with pO2 estimated from [18F]-EF5 positron emission tomography (PET) images. For the ROWD calculations, an RBE of 1.1 (RBE1.1,OER) and two variable RBE models, Rørvik (ROR) and McNamara (MCN), were used, alongside a reference plan without incorporation of OER (RBE1.1). Results For the HNC patients, treatment plans in line with the prescription dose and with acceptable target ROWD could be generated with the established tool. The physical dose was the main factor modulated in the ROWD. The impact of incorporating OER during optimization of HNC patients was demonstrated by the substantial difference found between ROWD and physical dose in the hypoxic tumor region. The largest physical dose differences between the ROWD optimized plans and the reference plan was 12.2 Gy. Conclusion The FLUKA MC based tool was able to optimize proton treatment plans taking the tumor pO2 distribution from hypoxia PET images into account. Independent of RBE-model, both elevated LET and physical dose were found in the hypoxic regions, which shows the potential to increase the tumor control compared to a conventional optimization approach.en_US
dc.language.isoengen_US
dc.publisherWileyen_US
dc.rightsNavngivelse 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/deed.no*
dc.titleCombined RBE and OER optimization in proton therapy with FLUKA based on EF5-PETen_US
dc.typeJournal articleen_US
dc.typePeer revieweden_US
dc.description.versionpublishedVersionen_US
dc.rights.holderCopyright 2023 The Author(s)en_US
dc.source.articlenumbere14014en_US
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1
dc.identifier.doi10.1002/acm2.14014
dc.identifier.cristin2149488
dc.source.journalJournal of Applied Clinical Medical Physicsen_US
dc.identifier.citationJournal of Applied Clinical Medical Physics. 2023, 24 (9), e14014.en_US
dc.source.volume24en_US
dc.source.issue9en_US


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

Navngivelse 4.0 Internasjonal
Med mindre annet er angitt, så er denne innførselen lisensiert som Navngivelse 4.0 Internasjonal